Global Rheumatoid Arthritis Market Analysis 2016 - Forecast to 2022

  • ID: 3845811
  • Report
  • Region: Global
  • 134 pages
  • Hoovers Research
1 of 3
This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Rheumatoid Arthritis". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:
- Market Sizing estimations and forecasts for a minimum of 6 years of all the given segments, sub segments and the regional markets
- Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Regional and country level market analysis
- Competitive landscaping mapping the key common trends
- Company profiling covering the financials, recent activities and the future strategies
- Supply chain trends mapping the recent advancements
- Strategic recommendations for the new entrants
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints
3.5 Pipeline Analysis

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Rheumatoid Arthritis Market by Product
5.1 Introduction
5.2 Analgesics
5.3 Corticosteroids
5.4 NSAIDs
5.5 Small-Molecule Disease-Modifying Anti-rheumatic Drugs
5.5.1 Xeljanz (tofacitinib) - Pfizer
5.5.2 Methotrexate-Based Products
5.6 Biologic Disease-Modifying Anti-rheumatic Drugs
5.6.1 AcellBia (rituximab biosimilar)
5.6.2 Actemra (tocilizumab) - Roche
5.6.3 Cimzia (certolizumab pegol) - UCB
5.6.4 Enbrel (etanercept) - Amgen, Pfizer and Takeda Pharmaceutical
5.6.5 Humira (adalimumab) - Abbvie
5.6.6 Kineret (anakinra) - Swedish Orphan Biovitrum
5.6.7 Orencia (abatacept) - Bristol-Myers Squibb
5.6.8 Reditux (Non-comparable Biologic of Rituxan)
5.6.9 Remicade (infliximab) - Johnson and Johnson, Merck
5.6.10 Remsima - infliximab biosimilar
5.6.11 Rituxan (rituximab) - Genentech (Roche), Biogen IDEC
5.6.12 Simponi (golimumab) - Johnson and Johnson, Merck

6 Rheumatoid Arthritis Market by Test Type
6.1 Introduction
6.2 RA Treatment Efficiency Monitoring Tests
6.2.1 Creatinine Test
6.2.2 Muscle Enzyme Tests (CPK, Aldolase)
6.2.3 Salicylate Level Count
6.3 Serology Test
6.3.1 Anti-Cyclic Citrullinated Peptide (Anti-CCP)
6.3.2 Antinuclear Antibody (ANA)
6.3.3 Erythrocyte Sedimentation Rate (Esr)
6.3.4 Rheumatoid Factor (Rf)
6.3.5 Uric Acid Test
6.3.6 Other Tests

7 Rheumatoid Arthritis Market by End User
7.1 Introduction
7.2 Ambulatory Surgical Centers
7.3 Hospital
7.4 Diagnostic Laboratories
7.4.1 Private Laboratories
7.4.2 Public Laboratories

8 Geographical Segmentation
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 RoW
8.4.1 Latin America
8.4.2 Middle East
8.4.3 Africa
8.4.4 Others

9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiles
10.1 Abbott Diagnostics (Abbott Laboratories)
10.1.1 Business Overview
10.1.2 SWOT Analysis
10.1.3 Financial Overview
10.1.4 Strategy
10.1.5 Key Activities
10.2 AbbVie
10.3 Amgen Inc.
10.4 Astellas
10.5 AstraZeneca- MedImmune
10.6 Bristol-Myers Squibb
10.7 Daiichi Sankyo
10.8 Eli Lilly
10.9 F. Hoffmann-La Roche
10.10 GlaxoSmithKline
10.11 Johnson & Johnson
10.12 Novartis
10.13 Pfizer Inc.
10.14 Roche
10.15 Sanofi
10.16 UCB
10.17 Vertex
11 Appendix
12 Disclaimer

List of Tables
Table 1 Global Rheumatoid Arthritis Market Analysis, by Region, 2013-2022 ($MN)
Table 2 Global Rheumatoid Arthritis Market Analysis, by Product, 2013-2022 ($MN)
Table 3 Global Analgesics Market Analysis, by Region, 2013-2022 ($MN)
Table 4 Global Analgesics Market Analysis, by Test Type, 2013-2022 ($MN)
Table 5 Global Analgesics Market Analysis, by End User, 2013-2022 ($MN)
Table 6 Global Corticosteroids Market Analysis, by Region, 2013-2022 ($MN)
Table 7 Global Corticosteroids Market Analysis, by Test Type, 2013-2022 ($MN)
Table 8 Global Corticosteroids Market Analysis, by End User, 2013-2022 ($MN)
Table 9 Global NSAIDs Market Analysis, by Region, 2013-2022 ($MN)
Table 10 Global NSAIDs Market Analysis, by Test Type, 2013-2022 ($MN)
Table 11 Global NSAIDs Market Analysis, by End User, 2013-2022 ($MN)
Table 12 Global Small-Molecule Disease-Modifying Anti-rheumatic Drugs Analysis, by Region, 2013-2022 ($MN)
Table 13 Global Small-Molecule Disease-Modifying Anti-rheumatic Drugs Analysis, by Test Type, 2013-2022 ($MN)
Table 14 Global Small-Molecule Disease-Modifying Anti-rheumatic Drugs Analysis, by End User, 2013-2022 ($MN)
Table 15 Global Biologic Disease-Modifying Anti-rheumatic Drugs Analysis, by Region, 2013-2022 ($MN)
Table 16 Global Biologic Disease-Modifying Anti-rheumatic Drugs Analysis, by Test Type, 2013-2022 ($MN)
Table 17 Global Biologic Disease-Modifying Anti-rheumatic Drugs Analysis, by End User, 2013-2022 ($MN)
Table 18 Global Rheumatoid Arthritis Market Analysis, by Test Type, 2013-2022 ($MN)
Table 19 Global RA Treatment Efficiency Monitoring Tests Market Analysis, by Region, 2013-2022 ($MN)
Table 20 Global RA Treatment Efficiency Monitoring Tests Market Analysis, by Product, 2013-2022 ($MN)
Table 21 Global RA Treatment Efficiency Monitoring Tests Market Analysis, by End User, 2013-2022 ($MN)
Table 22 Global Serology Test Market Analysis, by Region, 2013-2022 ($MN)
Table 23 Global Serology Test Market Analysis, by Product, 2013-2022 ($MN)
Table 24 Global Serology Test Market Analysis, by End User, 2013-2022 ($MN)
Table 25 Global Rheumatoid Arthritis Market Analysis, by End User, 2013-2022 ($MN)
Table 26 Global Ambulatory Surgical Centers Market Analysis, by Region, 2013-2022 ($MN)
Table 27 Global Ambulatory Surgical Centers Market Analysis, by Product, 2013-2022 ($MN)
Table 28 Global Ambulatory Surgical Centers Market Analysis, by Test Type, 2013-2022 ($MN)
Table 29 Global Hospital Market Analysis, by Region, 2013-2022 ($MN)
Table 30 Global Hospital Market Analysis, by Product, 2013-2022 ($MN)
Table 31 Global Hospital Market Analysis, by Test Type, 2013-2022 ($MN)
Table 32 Global Diagnostic Laboratories Market Analysis, by Region, 2013-2022 ($MN)
Table 33 Global Diagnostic Laboratories Market Analysis, by Product, 2013-2022 ($MN)
Table 34 Global Diagnostic Laboratories Market Analysis, by Test Type, 2013-2022 ($MN)
Table 35 North America Rheumatoid Arthritis Market Analysis, by Country, 2013-2022 ($MN)
Table 36 North America Rheumatoid Arthritis Market Analysis, by Product, 2013-2022 ($MN)
Table 37 North America Analgesics Market Analysis, by Country, 2013-2022 ($MN)
Table 38 North America Analgesics Market Analysis, by Test Type, 2013-2022 ($MN)
Table 39 North America Analgesics Market Analysis, by End User, 2013-2022 ($MN)
Table 40 North America Corticosteroids Market Analysis, by Country, 2013-2022 ($MN)
Table 41 North America Corticosteroids Market Analysis, by Test Type, 2013-2022 ($MN)
Table 42 North America Corticosteroids Market Analysis, by End User, 2013-2022 ($MN)
Table 43 North America NSAIDs Market Analysis, by Country, 2013-2022 ($MN)
Table 44 North America NSAIDs Market Analysis, by Test Type, 2013-2022 ($MN)
Table 45 North America NSAIDs Market Analysis, by End User, 2013-2022 ($MN)
Table 46 North America Small-Molecule Disease-Modifying Anti-rheumatic Drugs Analysis, by Country, 2013-2022 ($MN)
Table 47 North America Small-Molecule Disease-Modifying Anti-rheumatic Drugs Analysis, by Test Type, 2013-2022 ($MN)
Table 48 North America Small-Molecule Disease-Modifying Anti-rheumatic Drugs Analysis, by End User, 2013-2022 ($MN)
Table 49 North America Biologic Disease-Modifying Anti-rheumatic Drugs Analysis, by Country, 2013-2022 ($MN)
Table 50 North America Biologic Disease-Modifying Anti-rheumatic Drugs Analysis, by Test Type, 2013-2022 ($MN)
Table 51 North America Biologic Disease-Modifying Anti-rheumatic Drugs Analysis, by End User, 2013-2022 ($MN)
Table 52 North America Rheumatoid Arthritis Market Analysis, by Test Type, 2013-2022 ($MN)
Table 53 North America RA Treatment Efficiency Monitoring Tests Market Analysis, by Country, 2013-2022 ($MN)
Table 54 North America RA Treatment Efficiency Monitoring Tests Market Analysis, by Product, 2013-2022 ($MN)
Table 55 North America RA Treatment Efficiency Monitoring Tests Market Analysis, by End User, 2013-2022 ($MN)
Table 56 North America Serology Test Market Analysis, by Country, 2013-2022 ($MN)
Table 57 North America Serology Test Market Analysis, by Product, 2013-2022 ($MN)
Table 58 North America Serology Test Market Analysis, by End User, 2013-2022 ($MN)
Table 59 North America Rheumatoid Arthritis Market Analysis, by End User, 2013-2022 ($MN)
Table 60 North America Ambulatory Surgical Centers Market Analysis, by Country, 2013-2022 ($MN)
Table 61 North America Ambulatory Surgical Centers Market Analysis, by Product, 2013-2022 ($MN)
Table 62 North America Ambulatory Surgical Centers Market Analysis, by Test Type, 2013-2022 ($MN)
Table 63 North America Hospital Market Analysis, by Country, 2013-2022 ($MN)
Table 64 North America Hospital Market Analysis, by Product, 2013-2022 ($MN)
Table 65 North America Hospital Market Analysis, by Test Type, 2013-2022 ($MN)
Table 66 North America Diagnostic Laboratories Market Analysis, by Country, 2013-2022 ($MN)
Table 67 North America Diagnostic Laboratories Market Analysis, by Product, 2013-2022 ($MN)
Table 68 North America Diagnostic Laboratories Market Analysis, by Test Type, 2013-2022 ($MN)
Table 69 Europe Rheumatoid Arthritis Market Analysis, by Country, 2013-2022 ($MN)
Table 70 Europe Rheumatoid Arthritis Market Analysis, by Product, 2013-2022 ($MN)
Table 71 Europe Analgesics Market Analysis, by Country, 2013-2022 ($MN)
Table 72 Europe Analgesics Market Analysis, by Test Type, 2013-2022 ($MN)
Table 73 Europe Analgesics Market Analysis, by End User, 2013-2022 ($MN)
Table 74 Europe Corticosteroids Market Analysis, by Country, 2013-2022 ($MN)
Table 75 Europe Corticosteroids Market Analysis, by Test Type, 2013-2022 ($MN)
Table 76 Europe Corticosteroids Market Analysis, by End User, 2013-2022 ($MN)
Table 77 Europe NSAIDs Market Analysis, by Country, 2013-2022 ($MN)
Table 78 Europe NSAIDs Market Analysis, by Test Type, 2013-2022 ($MN)
Table 79 Europe NSAIDs Market Analysis, by End User, 2013-2022 ($MN)
Table 80 Europe Small-Molecule Disease-Modifying Anti-rheumatic Drugs Analysis, by Country, 2013-2022 ($MN)
Table 81 Europe Small-Molecule Disease-Modifying Anti-rheumatic Drugs Analysis, by Test Type, 2013-2022 ($MN)
Table 82 Europe Small-Molecule Disease-Modifying Anti-rheumatic Drugs Analysis, by End User, 2013-2022 ($MN)
Table 83 Europe Biologic Disease-Modifying Anti-rheumatic Drugs Analysis, by Country, 2013-2022 ($MN)
Table 84 Europe Biologic Disease-Modifying Anti-rheumatic Drugs Analysis, by Test Type, 2013-2022 ($MN)
Table 85 Europe Biologic Disease-Modifying Anti-rheumatic Drugs Analysis, by End User, 2013-2022 ($MN)
Table 86 Europe Rheumatoid Arthritis Market Analysis, by Test Type, 2013-2022 ($MN)
Table 87 Europe RA Treatment Efficiency Monitoring Tests Market Analysis, by Country, 2013-2022 ($MN)
Table 88 Europe RA Treatment Efficiency Monitoring Tests Market Analysis, by Product, 2013-2022 ($MN)
Table 89 Europe RA Treatment Efficiency Monitoring Tests Market Analysis, by End User, 2013-2022 ($MN)
Table 90 Europe Serology Test Market Analysis, by Country, 2013-2022 ($MN)
Table 91 Europe Serology Test Market Analysis, by Product, 2013-2022 ($MN)
Table 92 Europe Serology Test Market Analysis, by End User, 2013-2022 ($MN)
Table 93 Europe Rheumatoid Arthritis Market Analysis, by End User, 2013-2022 ($MN)
Table 94 Europe Ambulatory Surgical Centers Market Analysis, by Country, 2013-2022 ($MN)
Table 95 Europe Ambulatory Surgical Centers Market Analysis, by Product, 2013-2022 ($MN)
Table 96 Europe Ambulatory Surgical Centers Market Analysis, by Test Type, 2013-2022 ($MN)
Table 97 Europe Hospital Market Analysis, by Country, 2013-2022 ($MN)
Table 98 Europe Hospital Market Analysis, by Product, 2013-2022 ($MN)
Table 99 Europe Hospital Market Analysis, by Test Type, 2013-2022 ($MN)
Table 100 Europe Diagnostic Laboratories Market Analysis, by Country, 2013-2022 ($MN)
Table 101 Europe Diagnostic Laboratories Market Analysis, by Product, 2013-2022 ($MN)
Table 102 Europe Diagnostic Laboratories Market Analysis, by Test Type, 2013-2022 ($MN)
Table 103 Asia Pacific Rheumatoid Arthritis Market Analysis, by Country, 2013-2022 ($MN)
Table 104 Asia Pacific Rheumatoid Arthritis Market Analysis, by Product, 2013-2022 ($MN)
Table 105 Asia Pacific Analgesics Market Analysis, by Country, 2013-2022 ($MN)
Table 106 Asia Pacific Analgesics Market Analysis, by Test Type, 2013-2022 ($MN)
Table 107 Asia Pacific Analgesics Market Analysis, by End User, 2013-2022 ($MN)
Table 108 Asia Pacific Corticosteroids Market Analysis, by Country, 2013-2022 ($MN)
Table 109 Asia Pacific Corticosteroids Market Analysis, by Test Type, 2013-2022 ($MN)
Table 110 Asia Pacific Corticosteroids Market Analysis, by End User, 2013-2022 ($MN)
Table 111 Asia Pacific NSAIDs Market Analysis, by Country, 2013-2022 ($MN)
Table 112 Asia Pacific NSAIDs Market Analysis, by Test Type, 2013-2022 ($MN)
Table 113 Asia Pacific NSAIDs Market Analysis, by End User, 2013-2022 ($MN)
Table 114 Asia Pacific Small-Molecule Disease-Modifying Anti-rheumatic Drugs Analysis, by Country, 2013-2022 ($MN)
Table 115 Asia Pacific Small-Molecule Disease-Modifying Anti-rheumatic Drugs Analysis, by Test Type, 2013-2022 ($MN)
Table 116 Asia Pacific Small-Molecule Disease-Modifying Anti-rheumatic Drugs Analysis, by End User, 2013-2022 ($MN)
Table 117 Asia Pacific Biologic Disease-Modifying Anti-rheumatic Drugs Analysis, by Country, 2013-2022 ($MN)
Table 118 Asia Pacific Biologic Disease-Modifying Anti-rheumatic Drugs Analysis, by Test Type, 2013-2022 ($MN)
Table 119 Asia Pacific Biologic Disease-Modifying Anti-rheumatic Drugs Analysis, by End User, 2013-2022 ($MN)
Table 120 Asia Pacific Rheumatoid Arthritis Market Analysis, by Test Type, 2013-2022 ($MN)
Table 121 Asia Pacific RA Treatment Efficiency Monitoring Tests Market Analysis, by Country, 2013-2022 ($MN)
Table 122 Asia Pacific RA Treatment Efficiency Monitoring Tests Market Analysis, by Product, 2013-2022 ($MN)
Table 123 Asia Pacific RA Treatment Efficiency Monitoring Tests Market Analysis, by End User, 2013-2022 ($MN)
Table 124 Asia Pacific Serology Test Market Analysis, by Country, 2013-2022 ($MN)
Table 125 Asia Pacific Serology Test Market Analysis, by Product, 2013-2022 ($MN)
Table 126 Asia Pacific Serology Test Market Analysis, by End User, 2013-2022 ($MN)
Table 127 Asia Pacific Rheumatoid Arthritis Market Analysis, by End User, 2013-2022 ($MN)
Table 128 Asia Pacific Ambulatory Surgical Centers Market Analysis, by Country, 2013-2022 ($MN)
Table 129 Asia Pacific Ambulatory Surgical Centers Market Analysis, by Product, 2013-2022 ($MN)
Table 130 Asia Pacific Ambulatory Surgical Centers Market Analysis, by Test Type, 2013-2022 ($MN)
Table 131 Asia Pacific Hospital Market Analysis, by Country, 2013-2022 ($MN)
Table 132 Asia Pacific Hospital Market Analysis, by Product, 2013-2022 ($MN)
Table 133 Asia Pacific Hospital Market Analysis, by Test Type, 2013-2022 ($MN)
Table 134 Asia Pacific Diagnostic Laboratories Market Analysis, by Country, 2013-2022 ($MN)
Table 135 Asia Pacific Diagnostic Laboratories Market Analysis, by Product, 2013-2022 ($MN)
Table 136 Asia Pacific Diagnostic Laboratories Market Analysis, by Test Type, 2013-2022 ($MN)
Table 137 RoW Rheumatoid Arthritis Market Analysis, by Country, 2013-2022 ($MN)
Table 138 RoW Rheumatoid Arthritis Market Analysis, by Product, 2013-2022 ($MN)
Table 139 RoW Analgesics Market Analysis, by Country, 2013-2022 ($MN)
Table 140 RoW Analgesics Market Analysis, by Test Type, 2013-2022 ($MN)
Table 141 RoW Analgesics Market Analysis, by End User, 2013-2022 ($MN)
Table 142 RoW Corticosteroids Market Analysis, by Country, 2013-2022 ($MN)
Table 143 RoW Corticosteroids Market Analysis, by Test Type, 2013-2022 ($MN)
Table 144 RoW Corticosteroids Market Analysis, by End User, 2013-2022 ($MN)
Table 145 RoW NSAIDs Market Analysis, by Country, 2013-2022 ($MN)
Table 146 RoW NSAIDs Market Analysis, by Test Type, 2013-2022 ($MN)
Table 147 RoW NSAIDs Market Analysis, by End User, 2013-2022 ($MN)
Table 148 RoW Small-Molecule Disease-Modifying Anti-rheumatic Drugs Analysis, by Country, 2013-2022 ($MN)
Table 149 RoW Small-Molecule Disease-Modifying Anti-rheumatic Drugs Analysis, by Test Type, 2013-2022 ($MN)
Table 150 RoW Small-Molecule Disease-Modifying Anti-rheumatic Drugs Analysis, by End User, 2013-2022 ($MN)
Table 151 RoW Biologic Disease-Modifying Anti-rheumatic Drugs Analysis, by Country, 2013-2022 ($MN)
Table 152 RoW Biologic Disease-Modifying Anti-rheumatic Drugs Analysis, by Test Type, 2013-2022 ($MN)
Table 153 RoW Biologic Disease-Modifying Anti-rheumatic Drugs Analysis, by End User, 2013-2022 ($MN)
Table 154 RoW Rheumatoid Arthritis Market Analysis, by Test Type, 2013-2022 ($MN)
Table 155 RoW RA Treatment Efficiency Monitoring Tests Market Analysis, by Country, 2013-2022 ($MN)
Table 156 RoW RA Treatment Efficiency Monitoring Tests Market Analysis, by Product, 2013-2022 ($MN)
Table 157 RoW RA Treatment Efficiency Monitoring Tests Market Analysis, by End User, 2013-2022 ($MN)
Table 158 RoW Serology Test Market Analysis, by Country, 2013-2022 ($MN)
Table 159 RoW Serology Test Market Analysis, by Product, 2013-2022 ($MN)
Table 160 RoW Serology Test Market Analysis, by End User, 2013-2022 ($MN)
Table 161 RoW Rheumatoid Arthritis Market Analysis, by End User, 2013-2022 ($MN)
Table 162 RoW Ambulatory Surgical Centers Market Analysis, by Country, 2013-2022 ($MN)
Table 163 RoW Ambulatory Surgical Centers Market Analysis, by Product, 2013-2022 ($MN)
Table 164 RoW Ambulatory Surgical Centers Market Analysis, by Test Type, 2013-2022 ($MN)
Table 165 RoW Hospital Market Analysis, by Country, 2013-2022 ($MN)
Table 166 RoW Hospital Market Analysis, by Product, 2013-2022 ($MN)
Table 167 RoW Hospital Market Analysis, by Test Type, 2013-2022 ($MN)
Table 168 RoW Diagnostic Laboratories Market Analysis, by Country, 2013-2022 ($MN)
Table 169 RoW Diagnostic Laboratories Market Analysis, by Product, 2013-2022 ($MN)
Table 170 RoW Diagnostic Laboratories Market Analysis, by Test Type, 2013-2022 ($MN)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll